Document:

Translation of Agreement, dated January, 2008

 Exhibit 10.13 

AGREEMENT 

Made and executed in Ramat Gan this              day of January,
2008 
  

							
	BETWEEN:	  	Mr. Avraham Shkalim, I.D. 016314312	  	
		  	Of 24 Hashoshanim St., Nesher	  		  	
		  	(hereinafter: “Mr. Shkalim”)	  		  	

of the first part; 

 

							
	AND:	  	Company in Formation by D. Medical Industries Ltd.,
		  	Of 7 Jabotinsky Street, Ramat Gan	  		  	
		  	(hereinafter: “the Company in Formation”)	  		  	

of the second part; 

 

							
	AND:	  	D. Medical Industries Ltd., public company no. 520041955	  	
		  	Of 7 Jabotinsky Street, Ramat Gan	  		  	
		  	(hereinafter: “D. Medical”)	  		  	

 of the third part;

  

							
		
	WHEREAS 	  	D. Medical wishes to form a company that will carry on the business of developing, production, marketing and sale of disposable equipment for insulin pumps
(hereinafter: “the Disposable Equipment”) and/or any other act that relates to the Disposable Equipment; and 
		
	WHEREAS	  	The Company in Formation has entered into an agreement with Nilimedix Ltd., in connection with the Disposable Equipment, a copy of which Agreement is attached hereto
as an integral part thereof and marked as Appendix A; and
		
	WHEREAS	  	The Company wishes to receive development services in connection with the Disposable Equipment (hereinafter: “the Services”) from Mr. Shkalim
and Mr. Shkalim agrees to provide such development services to the Company, subject to the conditions hereinafter contained; and
		
	WHEREAS	  	The parties wish to enter into this Agreement in order to regulate the receipt of consulting and development services from Mr. Shkalim to the Company in
Formation;

 It is therefore declared, stipulated and agreed between the parties as follows:

  

	1.	Preamble and interpretation 

  

	 	1.1	The preamble to this Agreement constitutes an integral part hereof and will be read as one with the remaining sections thereof. 

 

	 	1.2	The headings of the sections in this Agreement are for convenience only and are not to be applied for purposes of interpretation. 

 

	 	1.3	No modification, addition to or derogation from this Agreement will have any effect following the date of the signature thereof unless made in writing and signed by all
the parties. 

  

	 	1.4	Unless otherwise stated in this Agreement, no provision contained in any of the terms and conditions contained in this Agreement will serve to derogate from any other
condition or provision herein contained but will be in addition thereto. 

  

	 	1.5	Terms and expressions in the singular include the plural and vice-versa, and the feminine includes the masculine and vice-versa and any references to individuals will
similarly extend to corporations and vice-versa. 

  

	 	1.6	Any Appendix attached hereto constitutes an integral part hereof. 

  

	2.	Warranties and Representations of Mr. Shkalim 

  

	 	2.1	Mr. Shkalim undertakes to invest approximately              hours a week of his time in
providing the Services to the Company in Formation, the consideration for Mr. Shkalim’s work to be paid to Nilimedix according to the Agreement that was signed between the Company in Formation and Nilimedix Ltd. (hereinafter:
“Nilimedix”). 

  

	 	2.2	All rights in the Disposable Equipment and/or in the intellectual property that may derive from it, including patents or applications to register patents, belong to the
Company in Formation. 

  

	3.	Allotment of shares to Mr. Shkalim in the Company in Formation  

 

	 	3.1	The parties agree that Mr. Shkalim will be entitled to an allotment of shares of the Company in Formation of a class having the highest preference that will be
held at any time by D. Medical, in the Company in Formation, which will reflect a holding rate by Mr. Shkalim of 9.9% (nine point nine percent) of the issued and paid up share capital of the Company in Formation on a fully diluted basis of all
the securities that will be allotted or granted by the Company in Formation at any time (hereinafter: “Full Dilution”). It is agreed that until US$ 1,000,000 (one million U.S. dollars) have been invested (excluding the sum of US$
700,000 that has been granted as a loan by D. Medical to the Company in Formation) in the capital, the holding rate of Mr. Shkalim will not be diluted below 9.9% of the capital of the Company in Formation as stated above as a result of an
allotment of securities of the Company in Formation to any person, including, but without limitation, to the investors who will invest the sum of up to US$ 1,000,000 as stated. It is clarified that to the extent an amount in excess of US$ 1,000,000
will be invested in the Company, Mr. Shkalim’s holding rate will be correspondingly diluted. 

  

	 	3.2	As long as Mr. Shkalim holds shares in the Company in Formation, Mr. Shkalim will be a director of the Company. 

 

	 	3.3	It is agreed that Mr. Shkalim will be the manager of the Company and that the Board of Directors of the Company may in the future change the manager’s
identity. 

  

	4.	Conversion of shares of the Company in Formation to shares of D. Medical 

 

	 	4.1	 The parties agree that should the sales of the Company in Formation exceed the sum of US$ 1 million (in the aggregate from the date of the
formation of the 

  

 2 

	 	 
Company in Formation) Mr. Shkalim will be entitled to convert, once, and without it being possible to convert on a number of occasions, all the warrants that are held by him in the Company
in Formation into 2,340,749 shares of D. Medical, without consideration, subject to the transfer of the share warrants that are held by him in the Company in Formation, to D. Medical. 

Mr. Shkalim’s entitlement to perform the transfer will be conditional on the fact that in addition to that stated above, the
sales of the Company in Formation will exceed the sales of Sindolor Medical Ltd., (a private company in which at the date of the execution of this Agreement, D. Medical holds shares). 

Conversion of the shares will be subject to the arrangement of all the tax matters that pertain to the conversion of the shares, by and at
the expense of Mr. Shkalim. 
  

	 	4.2	In addition to the foregoing it is agreed that D. Medical will have the right, subject to the fulfillment of the terms of section 4.1, to effect a forced conversion of
the warrants that are held by Mr. Shkalim in the Company in Formation into 2,340,749 shares of D. Medical. 

  

	 	4.3	It is agreed that in the event of Mr. Shkalim being unable to meet the tax payment applicable to him in respect of the forced conversion by D. Medical and/or will
not present an exemption from deduction of tax, Mr. Avraham Shkalim will transfer all his shares in the Company in Formation to a trustee who will effect the conversion and will be entitled to sell that number of D. Medical shares that is equal
to the amount required as a tax payment following conversion of the shares of the Company in Formation into D. Medical shares to such third party as will be determined by D. Medical. The balance of the shares following payment of such tax will be
returned to Mr. Avraham Shkalim. 

  

	5.	Bonus to Avraham Shkalim  

Mr. Shkalim will be entitled to the bonuses set out below: 

 

	 	5.1	If the sales of the Company in Formation exceed the sum of US$ 1 million (in the aggregate from the date of the formation of the Company in Formation, including
sales to Nilimedix Ltd.,), Mr. Shkalim will receive a bonus of US$ 250,000. 

  

	 	5.2	Should the sales of the Company in Formation exceed the sum of US$ 26 million (in the aggregate from the date of the formation of the Company in Formation,
including sales to Nilimedix Ltd.,), Mr. Shkalim will receive a bonus in addition to that stated in section 4.1 above in the sum of US$ 250,000 and in the aggregate, US$ 500,000. 

 

	 	5.3	Should the sales of the Company in Formation exceed the sum of US$ 51 million (in the aggregate from the date of the formation of the Company in Formation,
including sales to Nilimedix Ltd.,), Mr. Shkalim will receive a bonus in addition to that stated in section 4.2 above in the sum of US$ 250,000 and in the aggregate, US$ 750,000. 

 

	 	5.4	Should the sales of the Company in Formation exceed the sum of US$ 76 million (in the aggregate from the date of the formation of the Company in Formation,
including sales to Nilimedix Ltd.,), Mr. Shkalim will receive a bonus in addition to that stated in section 4.3 above in the sum of US$ 250,000 and in the aggregate, US$ 1,000,000. 

 

 3 

	 	5.5	The aggregate of all the bonuses to which Mr. Shkalim will be entitled will not exceed the sum of US$ 1,000,000. 

With respect to this Agreement, “sales” is as detailed in the financial statements of the Company in Formation. 

 

	6.	Taxes 

  

	 	6.1	The Company in Formation will bear stamp duty that will apply (if and to the extent it applies) in connection with this Agreement. 

 

	7.	Condition precedent  

This Agreement will enter into effect upon all of the following conditions being satisfied: 

 

	 	7.1	This Agreement is subject to the approval of the Board of Directors of the Company in Formation, which will be granted not later than 14 days after the date of the
execution of this Agreement. 

  

	 	7.2	This Agreement is subject to the approval of the Board of Directors of D. Medical, which will be granted not later than 14 days after the date of the execution of this
Agreement. 

  

	8.	Completion date of the transaction  

The transaction under this Agreement will be completed within 14 days of the date on which the Board of Directors of the Company in
Formation approves the transaction. 
  

	9.	Completion date of the transaction  

On the date of the completion of the transaction Mr. Shkalim and the Company in Formation will convene at the offices of the Company
in Formation and carry out the following actions: 
  

	 	9.1	The Company in Formation will furnish to Mr. Shkalim approval of the Board of Directors of the Company in Formation approving the Company’s entering into this
Agreement. 

  

	 	9.2	The Company in Formation will furnish to Advocate Victor Teshuva the allotment letters according to section 3 above. 

 

	10.	General  

 The parties
undertake to act in good faith and in mutual collaboration in order to execute the provisions of this Agreement including taking all actions, signing all documents and obtaining any approval that is required for the adequate performance of the terms
of this Agreement. 
  

 4 

 Notices 

 

	 	11.1	Notice sent according to the parties’ addresses set out at the head of this Agreement by registered mail will be deemed to have been received by the addressee
within 72 hours of being posted. Any such notice delivered in person will be deemed to have been received on the date of the service thereof. 

  

	 	11.2	Each party will be entitled to change its address for the purposes of this Agreement to another address in Israel by written notice that will be delivered to the other
at such address. 

  

	 	11.3	This Agreement will not be changed or amended except by instrument in writing that will be signed by all of the parties to this Agreement. Any change or amendment to or
in section 4 above will similarly be signed by D. Medical Industries Ltd., as a condition for the validity thereof. 

  

	 	11.4	No remedy conferred on any of the parties under this Agreement against the other shall exhaust the remedies that are conferred upon any party to this Agreement by law.

 In witness whereof the parties have set their hands at the time and place first above written: 

  

							
	 (signature)
	 		 	 (signature)
	 	
	The Company in Formation	 		 	Mr. Shkalim	 	
	By D. Medical Industries Ltd.	 		 		 	
				
	 (signature)
	 		 		 	
	D. Medical Industries Ltd.	 		 		 	

  

 5 

 Appendix A 

[See Exhibit 2.3 to the Registration Statement]Translation of a Form of Management Fees Agreement

 Exhibit 10.14 

[translation from Hebrew] 

Management Fee Agreement 

Entered into and signed in Ramat Gan on February 17, 2010 

 

					
	By and among:	 	D. Medical Industries Ltd.
		 	Public Company No. 520041955
		 	7 Jabutinsky St., Ramat Gan
		 	(hereinafter: “D Medical”)            On the first side
		
	And	 	[Nilimedix Ltd. /G Sense Ltd./MedexSet Ltd., as applicable]
		 	Private Company No. 513229708
		 	  
	 	
		 	(hereinafter: [“name of subsidiary (Nilimedix, G-Sense, MedexSet”]            
On the second side

  

			
	Whereas	 	Some of D Medical’s employees extend during their current employment certain management services to [name of subsidiary] (hereinafter “Management
Services”);
		
	and Whereas	 	[name of subsidiary] is interested in receiving from D Medical’s abovementioned employees the Management Services;
		
	and Whereas	 	D Medical declares that it has the human resources, the knowledge, the experience, the qualifications and the professional ability in order to extend to [name of subsidiary] the
Management Services;
		
	and Whereas	 	D Medical and [name of subsidiary] desire to determine the payment for the Management Services;

Now therefore, the parties agree as follows: 

 

	1.	Preamble and Interpretation 

  

	 	1.1.	The preamble to this agreement constitute an integral part hereof and shall be read in conjunction with its other provisions. 

 

	 	1.2.	The headings of the sections in this agreement are for convenience only and shall not be given any weight for the purpose of interpretation. 

 

	 	1.3.	No change, amendment, addition or deletion shall be valid after signing of this agreement unless made in writing and signed by all parties. 

	 	1.4.	No provision of this agreement derogates from any other provision of this agreement, rather to add thereon, unless otherwise provided in this agreement.

  

	 	1.5.	Any provision or expression in singular shall refer to plural also and vice versa and any masculine shall include feminine and vice versa and referring to a person
shall include an entity also and vice versa. 

  

	 	1.6.	All exhibits to this agreement shall constitute and integral part hereof. 

 

	2.	D Medical’s Representations 

Upon signing this agreement, D Medical represents as follows: 

 

	 	2.1.	This agreement and the execution of D Medical’s undertakings do not constitute a breach or are inconsistent with D Medical’s articles of association, any
agreement which D Medical is a party, and/or to any obligation by D Medical, whether by an agreement or by law, and there is no legal or any other prevention to its engagement in this agreement and to the execution of its undertaking according to
this agreement. 

  

	 	2.2.	D Medical has the human resources, the ability, the skill and the experience required, and it has all means, financial and others, in order to execute its undertakings
according to this agreement. 

  

	3.	[name of subsidiary] Representations 

Upon signing this agreement, [name of subsidiary] represents as follows: 

 

	 	3.1.	This agreement and execution of [name of subsidiary] undertakings do not constitute a breach or inconsistent with [name of subsidiary]’s articles of association,
an agreement which [name of subsidiary] is a party, and/or to any obligation by [name of subsidiary], whether by an agreement or by law, and there is no legal or any other prevention to its engagement in this agreement and to the execution of its
undertaking according to this agreement. 

  

	 	3.2.	[name of subsidiary] has all means, financial and others, in order to execute its undertakings according to this agreement. 

 

	4.	Providing Management Services  

  

	 	4.1.	As of November 1, 2009, (hereinafter: “Commencement Date of Providing Services”) D Medical provided and will provide to [name of subsidiary] the
Management Services. D Medical is providing and will provide the Management Services in dedication and efficiency and in a professional manner. Without derogating form the generality of the aforesaid, the Management Services shall include, among
others: 

  

	 	4.1.1.	Management Services through the chief executive officer of D Medical; 

	 	4.1.2.	Financial services through the chief financial officer of D Medical; 

  

	 	4.1.3.	Business development services through the business development officer of D Medical; 

 

	 	4.1.4.	Office space to the abovementioned employees in D Medical’s offices in Ramat Gan; 

 

	 	4.1.5.	Participation in current expenses and ancillary services. 

  

	5.	The Consideration 

  

	 	5.1.	As Consideration for the Management Services extended by D Medical to [name of subsidiary], [name of subsidiary] is paying to D Medical, as of the Commencement Date of
Providing Services a monthly consideration in the sum of NIS [            ], plus VAT as applicable by law (hereinafter: “Management Fees”). 

 

	 	5.2.	The payment for the Management Services shall be made against written evidence as required by law for the payment, plus VAT by law, if and to the extent that VAT will
be charged on the Management Services. 

  

	 	5.3.	 The consideration shall be paid to D Medical once every month, not later than the
9th day of every month, for Management Services provided
by D Medical to [name of subsidiary] in the previous month. 

  

	6.	The Term of the Agreement 

  

	 	6.1.	This agreement shall be effective as of the Commencement Date of Providing Services and shall remain in force for an unlimited period. 

 

	 	6.2.	Each party may terminate this agreement by furnishing a written notice to the other party, subject to a 90 days prior written notice. 

 

	7.	Approvals 

 Each
party to this agreement undertakes to receive all required approvals according to any law for the purpose of engaging in this agreement. 

	8.	Nature of Relations of D Medical and Nilimedix 

D Medical is an independent contractor for executing its obligations according to this agreement, and no employee-employer relations are
or will exist between the parties and/or between [name of subsidiary] and/or on its behalf, and D Medical and/or on its behalf, and the provisions of this agreement do not constitute employee-employer relations by any means between D Medical and/or
any of its employees and [name of subsidiary] and/or any of its employees. 
  

	9.	Notices 

  

	 	9.1.	Notice that will be delivered according to the parties’ addresses as detailed in the preamble to this agreement in registered mail shall be considered as received
by the addressee within 72 hours from its sending. If such notice is delivered by hand, it will be considered as received on the date of delivery. 

  

	 	9.2.	Each party may change its address for the purpose of this agreement to another address in Israel by a written notice which shall be delivered to the other party in the
said address. 

  

	 	9.3.	It is agreed that this Agreement shall be governed by laws of the State of Israel. The parties agree that any dispute arising under or in relation to this agreement
shall be resolved exclusively by the competent court in Tel Aviv-Jaffa. 

 IN WITNESS WHEREOF, each of the Parties has signed this
agreement as of the date first hereinabove set forth. 
  

			
	 [signature]
	    	 [signature]

	D. Medical Industries Ltd.	    	[name of subsidiary]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]